Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 346 to 360 of 814 results for mental health

  1. Suspected neurological conditions: recognition and referral (QS198)

    This quality standard covers assessing and referring children (under 16) and adults (16 and over) who have symptoms or signs associated with neurological conditions. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    8 January 2021
    View quality statements

    Sections for QS198

  2. Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessment (HTE27)

    Late stage assessment (LSA) guidance on topical antimicrobial dressings for locally infected leg ulcers....

    Health technology evaluation
    Published
    19 June 2025
    View recommendations

    Sections for HTE27

  3. Hip fracture in adults (QS16)

    This quality standard covers diagnosing and managing hip fracture in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    6 January 2023
    View quality statements

    Sections for QS16

  4. Medicines management for people receiving social care in the community (QS171)

    This quality standard covers assessing if people need help with their medicines and deciding what medicines support is needed to enable people to manage their medicines. It also includes communication between health and social care staff, to ensure people have the medicines support they need. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    24 July 2018
    View quality statements

    Sections for QS171

  5. Shared decision making (NG197)

    This guideline covers how to make shared decision making part of everyday care in all healthcare settings. It promotes ways for healthcare professionals and people using services to work together to make decisions about treatment and care. It includes recommendations on training, communicating risks, benefits and consequences, using decision aids, and how to embed shared decision making in organisational culture and practices.

    NICE guideline
    Published
    17 June 2021
    View recommendations

    Sections for NG197

  6. YOURmeds for medication support in long-term conditions (MIB289)

    NICE has developed a medtech innovation briefing (MIB) on YOURmeds for medication support in long-term conditions .

    Medtech innovation briefing
    Last updated
    9 June 2023

  7. Psychological interventions for children and young people with internalising disorders:- For children and young people with learning disabilities, what psychological interventions (such as cognitive behavioural therapy and interpersonal therapy) are clinically and cost effective for treating internalising disorders?

    randomised controlled trials. This research is crucial to improving the mental health outcomes in this population, and would have a...

    Research recommendation
    Published
    17 October 2016

  8. Letermovir for preventing cytomegalovirus disease after a stem cell transplant (TA591)

    Evidence-based recommendations on letermovir (Prevymis) for preventing cytomegalovirus disease after a stem cell transplant.

    Technology appraisal guidance
    Published
    31 July 2019
    View recommendations

    Sections for TA591

  9. Psychological interventions for depression and anxiety disorders in adults with mild to moderate learning disabilities:- For adults with milder learning disabilities, what is the clinical and cost effectiveness of psychological interventions such as cognitive behavioural therapy (modified for people with learning disabilities) for treating depression and anxiety disorders?

    improve quality of life and ultimately should reduce the demand for mental health and social care services.Modifications of CBT need to...

    Research recommendation
    Published
    17 October 2016

  10. What is the efficacy and cost effectiveness of rehabilitation services compared with treatment as usual for people with complex psychosis with residual disability, who are leaving early intervention services?

    complex psychosis. Qualitative evidence also showed that people with severe mental illness value rehabilitation. There was moderate...

    Research recommendation
    Published
    26 October 2020

  11. Pharmacological interventions for anxiety disorders in people with learning disabilities who have autism:- What is the clinical and cost effectiveness and safety of pharmacological interventions for anxiety disorders in people with learning disabilities who have autism?

    side effects and effectiveness may contribute to the under-treatment of mental health problems in people with learning disabilities who...

    Research recommendation
    Published
    17 October 2016

  12. Neutropenic sepsis: prevention and management in people with cancer (CG151)

    This guideline covers preventing, identifying and managing neutropenic sepsis in children, young people and adults receiving treatment for cancer in the community and in secondary and tertiary care. It aims to reduce the risk of infection in people with neutropenia (low number of white blood cells) who are receiving anticancer treatment and improve management of neutropenic sepsis.

    Clinical guideline
    Published
    19 September 2012
    View recommendations

    Sections for CG151

  13. Partial replacement of the meniscus of the knee using a biodegradable scaffold (IPG430)

    Evidence-based recommendations on partial replacement of the meniscus of the knee using a biodegradable scaffold. This involves placing a biodegradable implant into the meniscus to support regrowth and repair of the damage.

    Interventional procedures guidance
    Published
    23 July 2012
    View recommendations

    Sections for IPG430

  14. Sleepio to treat insomnia and insomnia symptoms (MTG70)

    Evidence-based recommendations on Sleepio to treat insomnia and insomnia symptoms.

    Medical technologies guidance
    Published
    20 May 2022
    View recommendations

    Sections for MTG70

  15. Type 2 diabetes in adults (QS209)

    This quality standard covers prevention of type 2 diabetes in adults (aged 18 and over) and care and treatment for adults with type 2 diabetes. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    2 March 2023
    View quality statements

    Sections for QS209